Download PDF
Open Access
CC BY-NC-ND 4.0 · South Asian J Cancer 2018; 07(03): 213-214
DOI: 10.4103/sajc.sajc_165_18
Letter to the Editor

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

Authors

  • Sachin Babanrao Dhumal

    Department of Medical Oncology Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Vijay M. Patil

    Department of Medical Oncology Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Amit Joshi

    Department of Medical Oncology Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Vanita Noronha

    Department of Medical Oncology Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Arun Chandrasekharan

    Department of Medical Oncology Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Prathamesh Pai

    Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Kumar Prabhash

    Department of Medical Oncology Tata Memorial Hospital, Mumbai, Maharashtra, India

Source of Support: Nill.
Further Information
Also available at
 PDF Download Permissions and Reprints
Preview Container


Publication History

Article published online:
22 December 2020

© 2018. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dubal PM, Bhojwani A, Patel TD, Zuckerman O, Baredes S, Liu JK, et al. Squamous cell carcinoma of the maxillary sinus: A population-based analysis. Laryngoscope 2016;126:399-404.
  • 2 Gibson TN, McNaughton DP, Hanchard B. Sinonasal malignancies: Incidence and histological distribution in Jamaica, 1973-2007. Cancer Causes Control 2017;28:1219-25.
  • 3 Al-Jhani AS, Al-Rajhi NM, El-Sebaie MM, Nooh NS, Mahasen ZZ, Al-Amro AS, et al. Maxillary sinus carcinoma. Natural history and outcome. Saudi Med J 2004;25:929-33.
  • 4 Iyer NG, Tan DS, Tan VK, Wang W, Hwang J, Tan NC, et al. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Cancer 2015;121:1599-607.
  • 5 Noronha V, Patil VM, Joshi A, Krishna MV, Dhumal S, Juvekar S, et al. Induction chemotherapy in technically unresectable locally advanced carcinoma of maxillary sinus. Chemother Res Pract 2014;2014:487872.
  • 6 Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y, et al. Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer 2001;92:1495-503.
  • 7 Santos MR, Servato JP, Cardoso SV, de Faria PR, Eisenberg AL, Dias FL, et al. Squamous cell carcinoma at maxillary sinus: Clinicopathologic data in a single Brazilian institution with review of literature. Int J Clin Exp Pathol 2014;7:8823-32.
  • 8 Waldron JN, O'Sullivan B, Gullane P, Witterick IJ, Liu FF, Payne D, et al. Carcinoma of the maxillary antrum: A retrospective analysis of 110 cases. Radiother Oncol 2000;57:167-73.